VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

Advanced Therapies Week 2022 | Collaborating with hospitals and industry in cell therapies

Cate Dyer, CEO & Founder, StemExpress, Folsom, CA, gives an overview of ongoing work by StemExpress in supporting the cell therapy manufacturers in terms of research & development, clinical trials and eventual commercialization. Isolation and collection of cells are a critical part in the production of cell therapies and StemExpress assists in the process, focusing on the logistics of delivering product to and from patients. This interview took place at Advanced Therapies Week 2022.

Disclosures

Cate Dyer is the CEO & Founder of StemExpress.